The Senior Leadership is the central decision-making and internal advisory body, and it is organized to be a diverse and representative group structured in order to encourage research productivity, promote interaction and collaboration, and take maximum advantage of institutional strengths and unique scientific opportunities. Dr. Eberlein has broad authority over all aspects of the Cancer Center and is the ultimate decision-maker for scientific and administrative matters. The Deputy Director and Associate Directors are accomplished, productive scientists, having served on study sections, as well as important national advisory boards. Dr. Timothy Eberlein has served as the Director ofthe Siteman Cancer Center (SCC) since 1998. He appointed Dr. John DiPersio as Deputy Director in 2000. Dr. Graham Colditz was recruited as Associate Director of Prevention and Control in 2007. Jeffrey Moley has served as Associate Director of Translational &Clinical Investigation since 1997. Michael Welch was appointed Associate Director of Oncologic Imaging in 2003. Helen Piwnica-Worms joined as Associate Director of Basic Science in 2009. Dr. Barry Sleckman was appointed Associate Director of Shared Resources in 2009. Dr. Craig Allred was appointed to the Senior Leadership representing Pathology in 2007. Mr. Brian Springer was recruited as Executive Director of Research and Business Administration in 2002. This group is joined by a group of Senior Leaders at Large - Drs. Paul Goodfellow (Endometrial SPORE PI), Dennis Hallahan (Chair, Radiation Oncology), Jeff Michalski (Director, Clinical Trials Core), and Richard Wilson (Director, Genome Center), and Mr. Richard Liekweg (President, Barnes-Jewish Hospital). The Senior Leaders integrate the SCC's research efforts, promote transdisciplinary interaction and collaboration, and set direction and priorities for the SCC. Since the initial CCSG submission in 2000, SCC extramural funding in cancer has increased nearly 100%, from $77 million to $153 million, and NCI funding has more than doubled, from $24 million to $55 million. During that time, the number of large collaborative grants and projects has grown from 8 to 40, and collaborative (inter- and intra-programmatic) publications are more than 31% of all publications today.
The Senior Leadership team of the Siteman Cancer Center sets the overall direction of the SCC, serving as the central decision-making and internal advisory body. They work to foster research productivity, promote interaction and collaboration, and take maximum advantage of institutional strengths and unique scientific opportunities that impact cancer diagnosis, treatment, and prevention.
|Zuiani, Adam; Chen, Kevin; Schwarz, Megan C et al. (2016) A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I. J Virol 90:10499-10512|
|Abboud, Ramzi; Keller, Jesse; Slade, Michael et al. (2016) Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. Biol Blood Marrow Transplant 22:1851-60|
|Johnson, Kimberly J; Zoellner, Nancy L; Gutmann, David H (2016) Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1. Cancer Epidemiol 42:53-9|
|Brownson, Ross C; Dodson, Elizabeth A; Kerner, Jon F et al. (2016) Framing research for state policymakers who place a priority on cancer. Cancer Causes Control 27:1035-41|
|Chou, Chun; Verbaro, Daniel J; Tonc, Elena et al. (2016) The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses. Immunity 45:570-82|
|Durai, Vivek; Murphy, Kenneth M (2016) Functions of Murine Dendritic Cells. Immunity 45:719-736|
|Beeman, Scott C; Shui, Ying-Bo; Perez-Torres, Carlos J et al. (2016) O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models. Magn Reson Med 75:2442-7|
|Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62|
|Niu, Haixia; Hadwiger, Gayla; Fujiwara, Hideji et al. (2016) Pathways of retinoid synthesis in mouse macrophages and bone marrow cells. J Leukoc Biol 99:797-810|
|Willet, Spencer G; Mills, Jason C (2016) Stomach Organ and Cell Lineage Differentiation: from Embryogenesis to Adult Homeostasis. Cell Mol Gastroenterol Hepatol 2:546-559|
Showing the most recent 10 out of 947 publications